Navigation LinksTop Biology NewsTop Medical NewsTop Biology TechnologyTop Medical Technology


Microbix Biosystems Re-files Annual Results With OSC

11/6/2009
TORONTO, Nov. 6 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (the "Company") announces today that it has re-filed the Form 52-109F1 Certification of Annual Filings of William Gastle, the Chief Executive Officer and James Long, the Chief Financial Officer (the "Officer's Certificates") dated January 12, 2009 in connection with the annual audited financial statements for the year ended... [Comments]

Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results

11/6/2009
LYNBROOK, N.Y., Nov. 6 BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical company developing first-in-class collagenase-based products, today announced its financial results for the third quarter ended September 30, 2009. "We were extremely happy that, in September of this year, the FDA's Arthritis Advisory Committee unanimously recommend... [Comments]

Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th

11/6/2009
AURORA, Ontario, Nov. 6 Helix BioPharma Corp. (TSX, FSE: "HBP" / Pink Sheets: HXBPF) today announced that John Docherty, president and chief operating officer, will present at Merriman Curhan Ford's 6th annual Investor Summit on November 10, 2009 at 4:00 PM at the Sofitel Hotel in New York City. Mr. Docherty will provide an overview of the Company's leading produ... [Comments]

Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants

11/6/2009
QUINCY, Mass., Nov. 6 Myriant Technologies LLC ("Myriant"), a privately-held, biotech developer and manufacturer of renewable bio-chemicals, Uhde Corporation of America and its preferred technology provider Uhde GmbH, one of the world's leading engineering contractors (jointly "Uhde"), announced an alliance for the engineering, procurement & construction (EPC) of Myria... [Comments]

EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus

11/6/2009
VIENNA, Austria, November 6 EUCODIS Bioscience, a companydeveloping, customizing, manufacturing, and marketing enzymes for thechemical industry announced today that it has entered into a researchagreement with Bio Sidus, the leading biopharmaceutical company in LatinAmerica. The agreement gives EUCODIS Bioscience exclusive access - for the searchof enzym... [Comments]

NeurogesX Reports Third Quarter 2009 Results

11/6/2009
SAN MATEO, Calif., Nov. 6 3Q09 Corporate Highlights: Completed transfer of Qutenza(TM) E.U. Marketing Authorization to Astellas Pharma Europe Ltd. Made significant progress in commercial readiness activities Expanded management team to include VP Sales; Senior Director, Marketing; and Director, Commercial Operations Appointed Bradford S. Good... [Comments]

Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus

11/6/2009
SPRING VALLEY, Calif., Nov. 6 Calbiotech, Inc. announced today that it has been awarded a Small Business Innovative Research (SBIR) Phase I contract by the U.S. Army Medical Research and Material command. Under terms of the agreement, Calbiotech will develop analyte specific reagents (ASRs) for the diagnosis of Dengue virus. Dengue virus is a mosquito-born flavivir... [Comments]

Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting

11/6/2009
CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:ONCY) ("Oncolytics" or the "Company") today announced updated results from a Phase II study of intravenous REOLYSIN(R) in patients with sarcomas metastatic to the lung in a poster presentation at the 15th Annual Connective Tissue Oncology Society Meeting held in Miami Beach, Florida, from November 5th to 7th.... [Comments]

Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting

11/6/2009
HAYWARD, Calif., Nov. 6 Intarcia Therapeutics, Inc. delivered two presentations today on its ITCA 650 (DUROS® continuous delivery of exenatide) program for the treatment of type 2 diabetes at the Ninth Annual Diabetes Technology Meeting in San Francisco, CA: (Logo: http://www.newscom.com/cgi-bin/prnh/20050301/SFTU126LOGO ) Continuous Subcutaneous Deliver... [Comments]

Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference

11/6/2009
The agenda for Arrowhead’s 2010 Personalized Medicine Partnerships Conference, which is set to take place on February 22-24, 2010 in Philadelphia, has been announced. At this three day conference we will highlight key issues in forming partnerships and engage the best speakers to share their experiences. Minneapolis, MN (PRWEB) November... [Comments]

[next]
(Date:11/5/2009)...ate University has been awarded a training grant i... Foundation under its Integrative Graduation Educa...s the first IGERT grant to be awarded to Kent Stat...ecovery and Reinvestment Act of 2009, runs through...ocuses on environment aquatic resource sensing (EA...
(Date:11/4/2009)...S: (top news in natural science) , United Stat...ses less water today than it did 35 years ago, des... water use are partly attributable to alternative ... irrigation systems. According to the latest USGS ... the United States goes to cooling thermoelectric ...
(Date:11/4/2009)...is, MO, November 4, 2009 Childhood obesity in the...ith more than one fourth of advertising on daytime...verages and continuing questions about the role te.../December issue of the Journal of Nutrition Educa...imed at children might be a large contributor to t...
Breaking Biology News(10 mins):Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3American Medical Association Passes Resolution Supporting Sustainable Food System 49307 1American Medical Association Passes Resolution Supporting Sustainable Food System 49307 2American Medical Association Passes Resolution Supporting Sustainable Food System 49307 3ORNL finding could help electronics industry enter new phase 49303 1ORNL finding could help electronics industry enter new phase 49303 2Teamsters Call on United Way to Aid Frontline Blood Drive Workers 49299 1Teamsters Call on United Way to Aid Frontline Blood Drive Workers 49299 2
...t greenhouse held more members of a rare species o...wild., This unusual bounty was the result of resea...student in the biological sciences department, wor...cCauley., The species is called the giant whorled ...ered in 1892 in Tennessee but was thought to be ex...
...le Oceanographic Institution (WHOI) will host an i...proposed iron fertilization of the ocean as a mean...ses in the atmosphere. , Several times over the ...rs have proposed spreading slurries of dissolved i...rs and promote vast blooms of marine plants (phyto...
...m to have a marked advantage over their rural cous...h larger range of conditions. , In fact, new res...hat the adaptability of many urban bird species me... what might be considered to be a very challenging...re severe than the habitats these birds historical...
Other Biology News:Student study bolsters case for adding a rare sunflower to the endangered species list 2Scientists, policymakers and industry leaders gather to discuss ocean iron fertilization 2City birds better than rural species in coping with human disruption 2
PerkinElmer Spectrum Beer's Law QUANT Quantitative Software, CD from PerkinElmer
...ro 1 is a dramatic breakthrough in accurate, small...s from 1mL with 10nL resolution, the micro 1 has u...ispenser. And, the micro 1 never needs re-calibrat...ch Screen programming on an LCD Display , Graphica...
... B3 series of microscopes offer all of the feature...ry work. Equipped with Koehler illumination, a cen...SC) objectives. The B3 is the workhorse of Motic's...be eliminates the need for re-focusing following a...
...rmo Sequenase Dye Primer Manual Cycle Sequencing K...eled primers and high-resolution fluorescence scan...tep followed by standard slab gel electrophoresis ...gged sequencing products. The kit components have...
Biology Products:
(Date:11/6/2009)...RNewswire-FirstCall/ -- BioSpecifics Technologies ...y developing first-in-class collagenase-based prod...e third quarter ended September 30, 2009. ,, "... year, the FDA,s Arthritis Advisory Committee unan...al of XIAFLEX(TM) for the treatment of Dupuytren,s...
(Date:11/6/2009)... ,, 3Q09 Corporate...a(TM) E.U. Marketing Authorization to Astellas Pha...mercial readiness activities Expanded management ...ng; and Director, Commercial Operations Appointed...t Committee chairman , Upcoming 2009 Milest...
(Date:11/6/2009)...genda for Arrowhead’s 2010 Personalized Medi... place on February 22-24, 2010 in Philadelphia, ha...will highlight key issues in forming partnerships ...ences. , Minneapolis, MN ...ad’s 2010 Personalized Medicine Partnership...
(Date:11/5/2009)... DSM Pharmaceutical Products today ...e with Galenix, Saint Jean D,Illac, France, where ...turing partner for Galenix commercial products on ...rate on business development opportunities co-mark... the strength of Galenix in drug product developme...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...d du Lac, Wis. -- Careers in manufacturing are hig...tage may be on the horizon. It appears a negative ...ges, assembly-line work and lay-offs - is thwartin... across the country. This despite a projected need...ding to the National Association of Manufacturers ...
...chburg, Wis. After breaking ground in October 20...hnology Campus has opened its doors to a full hou... held on Nov. 16 for the second New Venture Center...ompany, Imago Scientific . When it opens, Imago w...s, hoping to staff up to 71 over the next eight mo...
...coming the president of an international corporati...an be done with a PC, strong entrepreneurial spiri...self-employed seems daunting to many professionals...l within the first five years. If you,re the ,glas...such an estimate. , ,However, the typical entrepr...
Other Biology Technology:State campaign seeks to reverse negative perception of manufacturing work 2State campaign seeks to reverse negative perception of manufacturing work 3State campaign seeks to reverse negative perception of manufacturing work 4State campaign seeks to reverse negative perception of manufacturing work 5Fitchburg Technology Campus attracts nanotechnology firms 230 days to success: Three simple steps to create your own international startup 230 days to success: Three simple steps to create your own international startup 330 days to success: Three simple steps to create your own international startup 430 days to success: Three simple steps to create your own international startup 5